Filter by
Rare diseases and European Reference Networks - Key documents (69)
RSSCommission Report on the operation of Directive 2011/24/EU on the application of patients' rights in cross-border healthcare
Final report - Study on cross-border health services: enhancing information provision to patients
Member State Data on cross-border healthcare – Year 2016
Study - Cross-border cooperation: capitalising on existing initiatives for cooperation in cross-border regions
Final report - Patients’ Rights in the European Union: Mapping eXercise
Commission Decision on the adoption of a financing decision for 2017 and 2018 for the pilot project "Pilot project - Rare 2030 - a participatory…
Statement on the definition and minimum criteria for ERN Affiliated Partners
Final report – Study on cross-border health services: potential obstacles for healthcare providers
Commission Decision 2017/C 60/06 as regards the granting of individual licences to all Coordinators of the European Reference Networks to use the European Reference Network trademark
Final report – Study on better cross-border cooperation for high-cost capital investments in health
Member State Data on cross-border healthcare - Year 2015
Final report - Literature-based approach to defining the concept of healthcare which requires “highly specialised and cost-intensive medical…
Recommendations to support the incorporation of rare diseases into social services and policies
Recommendation on cross-border genetic testing of rare diseases in the European Union
Frequently Asked Questions (FAQs) on the procedural aspects on establishing ERNs
Commission report on the operation of Directive 2011/24/EU on the application of patients’ rights in cross-border healthcare
Rare disease European Reference Networks: Addendum to Eucerd recommendations of January 2013
Final report - Evaluative study on the cross-border healthcare Directive (2011/24/EU)
Recommendation on ways to improve codification for rare diseases in health information systems
Implementation report on the Commission Communication and Council Recommendation on rare diseases